flamboyant 200/12 / EMS - LARVOL DELTA

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma (clinicaltrials.gov) - P3 | N=134 | Recruiting | Sponsor: EMS | Not yet recruiting ➔ Recruiting | Trial completion date: Nov 2022 ➔ Oct 2023 | Trial primary completion date: Jun 2022 ➔ Jul 2023

Enrollment open • Trial completion date • Trial primary completion date • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases